Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Are the atypical forms of Guillain-Barré syndrome correlated with H1N1-influenza vaccination?

Li S, Zhu J.

Vaccine. 2012 Aug 17;30(38):5585. doi: 10.1016/j.vaccine.2012.06.024. Epub 2012 Jun 20. No abstract available.

PMID:
22728223
2.

Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.

Shaikh AG, Termsarasab P, Nwankwo C, Rao-Frisch A, Katirji B.

Vaccine. 2012 May 9;30(22):3251-4. doi: 10.1016/j.vaccine.2012.03.013. Epub 2012 Mar 17.

PMID:
22429755
3.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group.

Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13.

PMID:
23498095
4.

Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.

Polakowski LL, Sandhu SK, Martin DB, Ball R, Macurdy TE, Franks RL, Gibbs JM, Kropp GF, Avagyan A, Kelman JA, Worrall CM, Sun G, Kliman RE, Burwen DR.

Am J Epidemiol. 2013 Sep 15;178(6):962-73. doi: 10.1093/aje/kwt051. Epub 2013 May 6.

PMID:
23652165
5.

Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.

Choe YJ, Cho H, Bae GR, Lee JK.

Vaccine. 2011 Mar 3;29(11):2066-70. doi: 10.1016/j.vaccine.2011.01.007. Epub 2011 Jan 19.

PMID:
21255684
6.

Pandemic vaccines and small excess of Guillain-Barre cases.

[No authors listed]

BMJ. 2013 Mar 20;346:f1714. doi: 10.1136/bmj.f1714. No abstract available.

PMID:
23516147
7.

Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.

Vellozzi C, Iqbal S, Broder K.

Clin Infect Dis. 2014 Apr;58(8):1149-55. doi: 10.1093/cid/ciu005. Epub 2014 Jan 9. Review.

PMID:
24415636
8.

Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.

Andrews N, Stowe J, Al-Shahi Salman R, Miller E.

Vaccine. 2011 Oct 19;29(45):7878-82. doi: 10.1016/j.vaccine.2011.08.069. Epub 2011 Aug 27.

PMID:
21875631
9.

Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.

Verity C, Stellitano L, Winstone AM, Andrews N, Stowe J, Miller E.

Lancet. 2011 Oct 29;378(9802):1545-6. doi: 10.1016/S0140-6736(11)61665-6. No abstract available.

PMID:
22035553
10.

Pandemic (H1N1) 2009 influenza.

Polkinghorne B, Ward K, Totaro R.

N S W Public Health Bull. 2010 Jan-Feb;21(1-2):41-2. doi: 10.1071/NB09031. No abstract available.

11.

Guillain-Barré syndrome after H1N1 influenza: a concern.

Wiwanitkit V.

Neuroepidemiology. 2013;40(4):295. doi: 10.1159/000346274. Epub 2013 Mar 13. No abstract available.

12.

Guillain-Barré syndrome associated with H1N1 vaccination.

Marin LF, Abrahão A, Carvalho FA, Santos WA, Dallalba CC, Barcelos LB, Silva GS, Oliveira AS.

Arq Neuropsiquiatr. 2010 Dec;68(6):974-5. No abstract available. Erratum in: Arq Neuropsiquiatr. 2011 Feb;69(1):147. Abrahão, Ayessandro [corrected to Abrahão, Agessandro].

13.

Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.

Ghaderi S, Gunnes N, Bakken IJ, Magnus P, Trogstad L, Håberg SE.

Eur J Epidemiol. 2016 Jan;31(1):67-72. doi: 10.1007/s10654-015-0047-0. Epub 2015 May 26.

PMID:
26008750
14.

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; Global H1N1 GBS Consortium.

Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14.

PMID:
23770307
15.

Safety of influenza vaccination: Risk-benefit evaluation.

Wiwanitkit V.

Muscle Nerve. 2010 Aug;42(2):296; author reply 296. doi: 10.1002/mus.21676. No abstract available.

PMID:
20544931
16.
17.

Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.

Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, Stukel TA, Crowcroft NS, McGeer AJ, Zinman L, Deeks SL.

Lancet Infect Dis. 2013 Sep;13(9):769-76. doi: 10.1016/S1473-3099(13)70104-X. Epub 2013 Jun 28.

PMID:
23810252
18.

[Guillain-Barré syndrome secondary to H1N1 influenza vaccine].

López Nieto M, Gómez Garrido J, Losa Palacios A, Aguila Manso G.

Rev Clin Esp. 2010 Oct;210(9):485-6. doi: 10.1016/j.rce.2010.05.003. Epub 2010 Sep 15. Review. Spanish. No abstract available.

PMID:
20832792
19.

Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).

Souayah N, Yacoub HA, Khan HM, Michas-Martin PA, Menkes DL, Maybodi L, Qureshi AI.

Neuroepidemiology. 2012;38(4):227-32. doi: 10.1159/000336113. Epub 2012 Apr 27.

20.

[Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].

Press R, Andersen O.

Lakartidningen. 2010 Mar 10-16;107(10):666-7. Swedish. No abstract available.

PMID:
20402249

Supplemental Content

Support Center